{
    "clinical_study": {
        "@rank": "168272", 
        "arm_group": [
            {
                "arm_group_label": "V0111", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and the safety of the cream V0111 in\n      the treatment of fissure(s) situated on the heels in diabetic patients with polyneuropathy."
        }, 
        "brief_title": "Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Open Cracked Heel in Diabetic Patients With Polyneuropathy", 
        "condition_browse": {
            "mesh_term": "Polyneuropathies"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diabetes mellitus with neuropathy,\n\n          -  Cracked open heel with at least one fissure Grade 2,\n\n        Exclusion Criteria:\n\n          -  Open wound, skin infection, haemorrhagic crack on feet,\n\n          -  Major static disorder ,\n\n          -  Ulceration and history of ulceration,\n\n          -  Active haemorrhagic crack,\n\n          -  Hyperkeratotic disease\n\n          -  Diabetic arteriopathy,"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "162", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045199", 
            "org_study_id": "V00111 CR 0 02", 
            "secondary_id": "2013-A01394-41"
        }, 
        "intervention": [
            {
                "arm_group_label": "V0111", 
                "description": "Application twice a day during 28 days", 
                "intervention_name": "Tested product : V0111 cream", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Application twice a day during 28 days", 
                "intervention_name": "Placebo", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Diabetic Neuropathies", 
            "Diabetes Mellitus", 
            "Diabetic Foot", 
            "Diabetes Complications"
        ], 
        "lastchanged_date": "April 14, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bron", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muret", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pringy", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Orens de Gameville", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seysses", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tierce", 
                        "country": "France"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "contact_essais_cliniques@pierre-fabre.com", 
            "last_name": "Pierre Fabre M\u00e9dicament"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes", 
                "Belgium: Ethics Committee"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparison of the two treatment groups (verum versus placebo)", 
            "measure": "Complete healing of target fissure on the heel", 
            "safety_issue": "No", 
            "time_frame": "Day 28"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045199"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pierre Fabre Medicament", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pierre Fabre Medicament", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}